For more than a decade, there's been something fishy going on in a lake that straddles Vermont and the province of Quebec. It involves cancer, a kind of catfish, and — possibly — clues about how tumors metastasize.
Plastic surgery is becoming so normalized and undetectable, it's changing our relationship to reality. The New Yorker staff writer Jia Tolentino considers how beauty standards have dovetailed with AI.
President Trump plans to impose tariffs on imported generic medicines, his latest threat aimed at bringing pharmaceutical manufacturing back to the U.S.
At least 78 AHRQ grants worth $200 million have been affected by "non-award" notices; it's estimated those grants had $109.2 million in funding remaining.
Senior leaders must treat AI governance as their own daily job, not something the technology committee handles quarterly, write Peter Pronovost, Justin Norden, and Kedar Mate.
A panel of advisers to the Food and Drug Administration will meet this week to make recommendations on whether specialized pharmacies should be allowed to make some popular wellness peptides.
Funding cuts and program changes required by President Trump's big budget law are forcing states to rethink bipartisan efforts to bring Medicaid into jails and prisons.
Public health officials acknowledge they need to shed paternalistic messaging if they want to reach more people. The nominee to run the CDC says she will strike a new tone.